Development Level

Tbio 9 | 10,625
Tclin 7 | 602
Tchem 6 | 1,890
Tdark 3 | 7,003

Disease

ovarian cancer 15 | 8,491
non-small cell lung cancer 11 | 2,798
lung cancer 10 | 4,473
colon cancer 8 | 1,475
psoriasis 8 | 6,685
Acute lymphoid leukemia 7 | 25
Anaplastic large T-cell systemic malignant lymphoma 7 | 10
Burkitt's lymphoma 7 | 15
Carcinoma of breast 7 | 11
Carcinoma of female breast 7 | 20
Diffuse non-Hodgkin's lymphoma, large cell 7 | 12
Follicular non-Hodgkin's lymphoma 7 | 17
Gestational trophoblastic neoplasia 7 | 14
HER2-positive carcinoma of breast 7 | 10
Hodgkin's disease 7 | 18
Hypertensive disorder 7 | 58
Kaposi's sarcoma 7 | 20
Langerhans cell histiocytosis, disseminated 7 | 10
Liposarcoma 7 | 20
Malignant tumor of head and/or neck 7 | 15
Malignant tumor of ovary 7 | 25
Malignant tumor of prostate 7 | 26
Malignant tumor of stomach 7 | 12
Malignant tumor of testis 7 | 11
Metastatic Breast Carcinoma 7 | 21
Metastatic Prostate Carcinoma 7 | 18
Multiple myeloma 7 | 1,327
Mycosis fungoides 7 | 30
Nephroblastoma 7 | 45
Neuroblastoma 7 | 78
Non-Hodgkin's lymphoma 7 | 22
Ocular hypertension 7 | 27
Open-angle glaucoma 7 | 26
Rhabdomyosarcoma 7 | 29
Secondary malignant neoplasm of pancreas 7 | 10
breast carcinoma 7 | 1,614
dermatomyositis 7 | 966
transitional cell carcinoma 7 | 20
Breast cancer 6 | 3,098
Condyloma acuminatum 6 | 7
glioblastoma 6 | 5,572
medulloblastoma, large-cell 6 | 6,234
osteosarcoma 6 | 7,933
pancreatic cancer 6 | 2,300
Lissencephaly 5 | 61
Waldenstrons macroglobulinemia 5 | 764
acute quadriplegic myopathy 5 | 1,157
group 3 medulloblastoma 5 | 2,254
intraductal papillary-mucinous carcinoma (IPMC) 5 | 2,988
nasopharyngeal carcinoma 5 | 1,056
Duchenne muscular dystrophy 4 | 602
astrocytic glioma 4 | 2,241
atypical teratoid / rhabdoid tumor 4 | 4,369
intraductal papillary-mucinous neoplasm (IPMN) 4 | 3,289
invasive ductal carcinoma 4 | 2,950
lung adenocarcinoma 4 | 2,714
malignant mesothelioma 4 | 3,163
pediatric high grade glioma 4 | 2,712
pilocytic astrocytoma 4 | 3,086
Amyotrophic Lateral Sclerosis 3 | 432
Becker muscular dystrophy 3 | 187
HIV Infections 3 | 99
Microcephaly 3 | 149
Pick disease 3 | 1,893
autosomal dominant Emery-Dreifuss muscular dystrophy 3 | 499
diabetes mellitus 3 | 1,663
ependymoma 3 | 2,514
intraductal papillary-mucinous adenoma (IPMA) 3 | 2,956
juvenile dermatomyositis 3 | 1,189
oligodendroglioma 3 | 2,849
posterior fossa group B ependymoma 3 | 1,530
primitive neuroectodermal tumor 3 | 3,031
ulcerative colitis 3 | 2,087
Acute coronary syndrome 2 | 37
Cancer 2 | 2,346
Down syndrome 2 | 548
Mammary Neoplasms 2 | 410
Neuropathy 2 | 210
Osteoporosis 2 | 259
Peripheral Neuropathy 2 | 303
Stomach Neoplasms 2 | 282
atypical teratoid/rhabdoid tumor 2 | 1,095
gastric cancer 2 | 436
gastric carcinoma 2 | 832
hepatocellular carcinoma 2 | 550
inflammatory breast cancer 2 | 404
interstitial cystitis 2 | 2,299
limb girdle muscular dystrophy 2B 2 | 74
lung carcinoma 2 | 2,844
mucosa-associated lymphoid tissue lymphoma 2 | 480
non diabetic and post-ischemic heart failure 2 | 200
pancreatic carcinoma 2 | 567
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,795
primary pancreatic ductal adenocarcinoma 2 | 1,271
sonic hedgehog group medulloblastoma 2 | 1,482
tuberculosis 2 | 1,563
Distal arthrogryposis 1 | 45
Muscle Weakness 1 | 92
Ptosis 1 | 42
active ulcerative colitis 1 | 477

Tissue

Blood and immune system 25 | 17,994
Cardiovascular System 25 | 17,957
Digestive Tract 25 | 18,472
Endocrine System 25 | 18,511
Female tissues 25 | 18,646
Liver and Pancreas 25 | 18,135
Male tissues 25 | 17,968
Nervous System 25 | 18,560
Respiratory system 25 | 17,483
Skin and soft tissues 25 | 18,114
Urinary Tract 25 | 18,443

Target Family

Non-IDG 25 | 11,969

Reactome Pathway

Formation of tubulin folding i... 25 | 25
Signal Transduction 2,515 | 2,515
Immune System 2,183 | 2,183
Metabolism 2,131 | 2,131
Gene Expression 1,754 | 1,754
Metabolism of proteins 1,544 | 1,544
Innate Immune System 1,375 | 1,375
Signaling by GPCR 1,329 | 1,329
Developmental Biology 1,028 | 1,028
GPCR downstream signaling 1,015 | 1,015
Post-translational protein mod... 1,004 | 1,004
Adaptive Immune System 938 | 938
Disease 855 | 855
Generic Transcription Pathway 852 | 852
Cytokine Signaling in Immune s... 803 | 803
Metabolism of lipids and lipop... 797 | 797
Vesicle-mediated transport 705 | 705
Hemostasis 669 | 669
Transmembrane transport of sma... 668 | 668
Membrane Trafficking 608 | 608
Cell Cycle 572 | 572
Neutrophil degranulation 542 | 542
Axon guidance 541 | 541
Signaling by Interleukins 500 | 500
Cell Cycle, Mitotic 470 | 470
Signalling by NGF 467 | 467
GPCR ligand binding 456 | 456
Gastrin-CREB signalling pathwa... 435 | 435
Class I MHC mediated antigen p... 430 | 430
Olfactory Signaling Pathway 430 | 430
Fc epsilon receptor (FCERI) si... 423 | 423
Cellular responses to stress 415 | 415
DAP12 interactions 409 | 409
Infectious disease 391 | 391
NGF signalling via TRKA from t... 378 | 378
Signaling by Rho GTPases 378 | 378
Signaling by PDGF 367 | 367
Diseases of signal transductio... 359 | 359
Transcriptional Regulation by ... 356 | 356
Signaling by EGFR 355 | 355
Metabolism of amino acids and ... 353 | 353
DAP12 signaling 346 | 346
Downstream signal transduction 343 | 343
Neuronal System 343 | 343
Organelle biogenesis and maint... 334 | 334
Signaling by VEGF 329 | 329
Signaling by SCF-KIT 327 | 327
Class A/1 (Rhodopsin-like rece... 322 | 322
VEGFA-VEGFR2 Pathway 321 | 321
FCERI mediated MAPK activation 316 | 316
Signaling by Insulin receptor 312 | 312
Antigen processing: Ubiquitina... 301 | 301
Extracellular matrix organizat... 292 | 292
Signaling by Type 1 Insulin-li... 290 | 290
Signaling by Wnt 290 | 290
IGF1R signaling cascade 289 | 289
IRS-related events triggered b... 289 | 289
Insulin receptor signalling ca... 288 | 288
Metabolism of carbohydrates 288 | 288
DNA Repair 286 | 286
IRS-mediated signalling 285 | 285
MAPK family signaling cascades 283 | 283
Asparagine N-linked glycosylat... 282 | 282
Signaling by the B Cell Recept... 282 | 282
SLC-mediated transmembrane tra... 280 | 280
Deubiquitination 277 | 277
Interferon Signaling 275 | 275
Platelet activation, signaling... 274 | 274
NCAM signaling for neurite out... 268 | 268
M Phase 266 | 266
Interleukin-3, 5 and GM-CSF si... 262 | 262
RET signaling 261 | 261
Signalling to ERKs 254 | 254
Interleukin-2 signaling 253 | 253
Immunoregulatory interactions ... 252 | 252
RHO GTPase Effectors 249 | 249
VEGFR2 mediated cell prolifera... 249 | 249
Signalling to RAS 247 | 247
Interleukin receptor SHC signa... 246 | 246
G alpha (i) signalling events 245 | 245
Fatty acid, triacylglycerol, a... 244 | 244
Signaling by Leptin 244 | 244
Prolonged ERK activation event... 243 | 243
MAPK1/MAPK3 signaling 242 | 242
Frs2-mediated activation 241 | 241
HIV Infection 241 | 241
ARMS-mediated activation 240 | 240
Signalling to p38 via RIT and ... 240 | 240
Chromatin modifying enzymes 237 | 237
Chromatin organization 237 | 237
GRB2 events in EGFR signaling 236 | 236
RAF/MAP kinase cascade 236 | 236
SHC1 events in EGFR signaling 236 | 236
SOS-mediated signalling 236 | 236
Processing of Capped Intron-Co... 235 | 235
Biological oxidations 215 | 215
Keratinization 213 | 213
Transmission across Chemical S... 210 | 210
rRNA processing 209 | 209
Ion channel transport 204 | 204
Phospholipid metabolism 202 | 202

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
T-complex protein 1 subunit alpha TCP1 Tbio Non-IDG -2.24310 169.4 383
Tubulin beta-2A chain TUBB2A Tclin Non-IDG -1.58354 36.1 215
Tubulin beta-2B chain TUBB2B Tclin Non-IDG -1.18576 14.1 136
Tubulin beta-1 chain TUBB1 Tclin Non-IDG -1.31539 16.7 219
T-complex protein 1 subunit theta CCT8 Tbio Non-IDG -1.47127 29.4 180
T-complex protein 1 subunit delta CCT4 Tbio Non-IDG -1.77071 56.6 151
T-complex protein 1 subunit epsilon CCT5 Tbio Non-IDG -1.43676 24.5 183
Tubulin alpha-1A chain TUBA1A Tchem Non-IDG -1.55557 35.2 218
T-complex protein 1 subunit zeta-2 CCT6B Tdark Non-IDG -0.44630 2.85 52
Putative tubulin-like protein alpha-4B TUBA4B Tdark Non-IDG 0.00000 0